Centers | ||
Drug Discovery Unit | FDA Oncology Center of Excellence Project Catalyst | Therapeutic Accelerator Program (TAP) |
The Drug Discovery Unit (DDU) is a fully integrated drug discovery group established to translate world-class biology research into novel drug targets and candidate drugs. Housed within purpose built facilities at the University of Dundee, the DDU... Read more |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
Test |
Partnerships |
Events |
Jobs |
Sanofi and Weill Cornell Medical College to Discover New Drus to Treat TuberculosisSanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment of tuberculosis and increase effectiveness of... View all Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all Creative BioMart
View all |
Join us for the annual meeting of the Association of Medical School Neuroscience Department... 08 February, 2023NIH Course in Neurotherapeutics Discovery and Development for Academic Scientists March -... 14 March, 2023The ABE 2023 Annual Meeting will take place on April 30-May 4 at the Kiawah Island Resort in... |
Director, Center for Drug Discovery
... 22 November, 2022 Learn More Post-doctoral Research Fellow in Gene Therapy
id: 22560 Postdoctoral Fellowship in Metastatic Cancer Research
id: 22561 Postdoctoral Fellowship in Obesity and Metabolism Research
id: 22564 |